WST — West Pharmaceutical Services, Inc.
$416.42
+$5.12 (+1.24%)
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Market Cap
$29.01B
Forward P/E
40.1x
52-Week Range
N/A
WST Price History
Revenue vs. Net Income
$3.1B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$469M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
16.6%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
3.9x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
9.3%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-1.4%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
